BRISBANE, Calif.--(BUSINESS WIRE)--Aimmune Therapeutics, Inc. (Nasdaq:AIMT), a biopharmaceutical company developing desensitization treatments for food allergies, today announced that it will present at the Bank of America Merrill Lynch Global Healthcare Conference in London.
About the Presentation
• Friday, September 18, 2015, at 9:45 a.m. GMT
Help employers find you! Check out all the jobs and post your resume.
